Concepedia

Publication | Closed Access

An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals

DOI

162

Citations

16

References

2003

Year

Mark Nelson, Simon Portsmouth, Justin Stebbing, Mark Atkins, Andrew Barr, Gail Matthews, Deenan Pillay, MJ Fisher, Mark Bower, Brian Gazzard
AIDS

Abstract

These results indicate that 52 weeks of tenofovir in addition to antiretroviral therapy is active against HBV, and it appears to overcome lamivudine resistance.

References

YearCitations

Page 1